| Literature DB >> 29515621 |
Fiammetta Monacelli1,2, Alessio Signori3, Matteo Prefumo1,2, Chiara Giannotti1,2, Alessio Nencioni1,2, Emanuele Romairone4, Stefano Scabini4, Patrizio Odetti1.
Abstract
BACKGROUND/AIMS: Postoperative delirium (POD) is more frequent in elderly patients undergoing major cancer surgery. The interplay between individual clinical vulnerability and a series of perioperative factors seems to play a relevant role. Surgery is the first-line treatment option for cancer, and fast-track surgery (FTS) has been documented to decrease postoperative complications. The study sought to assess, after comprehensive geriatric assessment (CGA) and frailty stratification (Rockwood 40 items index), which perioperative parameters were predictive of POD development in elderly patients undergoing FTS for colorectal cancer.Entities:
Keywords: Delirium; Functional impairment; Geriatrics; Neuroinflammatory aspects of dementia and delirium
Year: 2018 PMID: 29515621 PMCID: PMC5836168 DOI: 10.1159/000486519
Source DB: PubMed Journal: Dement Geriatr Cogn Dis Extra ISSN: 1664-5464
Fast-track colorectal surgery protocol
| Anesthesiology assessment |
| Comprehensive geriatric assessment |
| Cardiologist visit if needed |
| Diabetologist visit if needed |
| Pulmonologist visit if needed |
| Nutritionist visit for tailored nutritional intervention along with standard oral hypercaloric supplementation (2 days, 600 kcal/day) if needed |
| Physiotherapist assessment for pre-and postoperative rehabilitative plan and training if needed |
| Peridural catheter or peripheral venous access for pain control |
| General anesthesia with propofol and remifentanil by target control technique |
| Total intravenous liquid infusion (saline solution 0.9% 6 mL/kg/h + 500 mL hydroxyethylamide 130/0.4) |
| Mechanical or physical devices to maintain normothermia if needed |
| Ondansetron 4 mg 30 min before intubation |
| Hemotransfusion if blood pressure <20% estimated basal value |
| Droperidol 0.625 mg after surgery |
| Urinary catheter placement/drainage placement/peripheral venous access placement |
| Nasogastric tube placement and removal after surgery |
| Surgical technique |
| Laparotomy |
| Laparoscopy |
| Mean duration of surgery (155 ± 55 min) |
| Laparotomy |
| Laparoscopy |
| Analgesic control: Peridural catheter or by peripheral venous access with acetaminophen 1 g i.v. × 4/day and tramadol 100 mg i.v. if needed (pain control: numeric rating scale [NRS] <4/10) |
| Trunk control and patient seated for at least 2 h a day |
| Respiratory rehabilitation for 10 min a day |
| Early oral liquid assumption (maximum 1 L a day) if possible |
| Oral nutritional supplementation (protein and caloric supplementation 300 kcal/day per single supplement) if possible or parenteral i.v. nutrition (1,000 mL/day, 700 kcal/day) for 5 consecutive days after surgery |
| Bowel evacuation daily and peristalsis assessment |
| Analgesic control: acetaminophen 1 g × 4/day and tramadol 100 mg/day if needed (pain control: NRS <4/10) |
| From day 3 to day 5 after surgery: pain control: peridural catheter withdrawal and oral analgesic therapy: paracetamol 300 mg and oxycodone 5 mg 3 tablets a day OR paracetamol 300 mg and oxycodone 10 mg 3 tablets a day (pain control: NRS <4/10); if needed, ketorolac 30 mg i.m. (maximum 90 mg in 24 h) |
| Trunk control and patient seated for 6–8 h a day |
| Walking rehabilitation from 3 to 5 times a day |
| Respiratory rehabilitation for 10 min 4 times a day |
| Early oral liquid assumption (maximum 1 L a day) if possible |
| Oral nutritional supplementation (protein and caloric supplementation) if possible or parenteral i.v. nutrition (1,000 mL/day, 700 kcal/day) for 5 consecutive days after surgery |
| Bowel evacuation daily, peristalsis assessment, and normal bowel movement |
| Parenteral nutrition withdrawal and oral normal feeding (3 meals a day) with oral nutritional supplementation (2 a day, if needed) |
| Withdrawal surgical drainage |
| Withdrawal urinary catheter |
Factors precipitating POD in elective fast-track surgery oncogeriatric patients: standardized clinical parameters according to fast-track protocol
| Standardized clinical protocol for nutrition: oral supplementation (300 kcal/day for 1 supplement day and/or i.v. parenteral nutrition (1,000 mL i.v./day for 5 days; 700 kcal/day) |
| Standardized device use (peripheral venous access, urinary catheter, and abdominal drainage) |
| Standardized clinical protocol for constipation (osmotic agents for 7 days) with daily report of patient bowel evacuation and movement |
| Standardized clinical protocol for pain (i.v. paracetamol 1 g a day for 48 h) and additional narcotics given above standards record |
| Standardized application of bedrail constraints for 72 h |
| Plasmatic determination of hemoglobin, creatinine, sodium, potassium, C-reactive protein, after 48/72 h from surgery |
| Incident postoperative drug administration record |
| Postoperative blood transfusion record |
Patients' clinical characteristics based on Comprehensive Geriatric Assessment (CGA) and Rockwood Frailty Index (40-item FI)
| Assessment tool | Mean ± SD |
|---|---|
| MMSE | 27.13±0.35 |
| CIRS | 4.39±0.19 |
| CDT | 2.57±0.15 |
| 4ATtest | 3.47±0.23 |
| Tinetti | 24.29±0.57 |
| MNA | 23.32±0.32 |
| Barthel index | 97.68±0.65 |
| IADL | 7.19±0.16 |
| GDS | 3.62±0.32 |
| Gijon scale | 8.71±0.26 |
| NRS | 0.60±0.18 |
| TUG | 10.84±0.59 |
| CGA | 3.48±0.23 |
| Rockwood FI (40 items) | 0.23±0.01 |
| ASA | 2.28±0.07 |
| Dindo-Clavien | 1.07±0.12 |
| SF36 | 0.73±0.05 |
| Karnofsky | 89.38±1.19 |
| ECOG PS | 0.37±0.06 |
| Mean drugs | 4.82±0.29 |
SD, standard deviation. For other abbreviations, see Table 4.
97 patients: no missing data.
Comparisons between predisposing factors, precipitating factors in delirious patients and nondelirious patients
| Clinical parameters | Delirious ( | Nondelirious ( | |
| Age, years | 80.02±0.45 | 80.05±0.34 | 0.5 |
| 4AT score | 8.61±0.71 | 2.68±0.07 | <0.0001 |
| ASA score | 2.28±0.43 | 2.98±0.23 | 0.5 |
| MMSE score | 24.31±1.14 | 27.56±0.34 | <0.02 |
| CIRS | 5.46±0.44 | 4.22±0.20 | 0.12 |
| CDT | 3.36±0.38 | 2.45±0.16 | 0.09 |
| MNA | 22.38±0.89 | 23.47±0.16 | 0.46 |
| Barthel index | 93.08±2.56 | 98.39±5.71 | <0.02 |
| IADL | 6.00±0.63 | 7.37±0.15 | 0.03 |
| GDS | 3.84±1.03 | 3.58±0.33 | 0.95 |
| Gijon scale | 10.08±0.81 | 8.50±0.26 | 0.33 |
| Tinetti score | 19.69±1.94 | 25.02±0.55 | <0.01 |
| NRS | 1.07±0.47 | 0.53±0.19 | <0.04 |
| TUG score | 18.15±2.55 | 9.63±0.42 | <0.02 |
| CGA score | 5.69±2.05 | 3.14±0.24 | <0.005 |
| RI | 0.29±0.04 | 0.22±0.01 | 0.15 |
| Dindo-Clavien score | 1.07±0.34 | 1.07±1.19 | 0.58 |
| SF36 score | 0.90±0.26 | 0.70±0.04 | 0.43 |
| Karnofsky score | 82.31±4.55 | 90.48±1.16 | 0.25 |
| ECOG PS | 0.69±0.23 | 0.32±0.06 | 0.42 |
| Hemoglobin, g/dL | 10.72±0.44 | 10.90±0.16 | 0.79 |
| Sodium, MEq/L | 140.30±0.67 | 140.7±0.33 | 0.49 |
| Potassium, MEq/L | 4.07±4.59 | 4.06±0.05 | 0.07 |
| Creatinine, mg/dL | 1.35±0.13 | 1.16±0.04 | 0.17 |
| Mean drugs | 4.35±1.23 | 4.01±0.11 | 0.33 |
MMMSE, Mini-Mental State Examination – cognitive status; CDT, Clock drawing test Shulman 1 – visuospatial impairment; 4AT, rapid assessment test for delirium – screening test for delirium; CIRCS, Cumulative Illness Rate Scale for Geriatrics – multimorbidity; MNA, Mini-Nutritional Assessment – nutritional status; Barthel Index, functional status; IADL, Instrumental Activities of Daily Living – functional status; GDS, Geriatric Depression Scale – depression; Gijon scale – social frailty; Tinetti Scale – risk of falls; NRS, Numeric Rate Scale – pain; CGA, comprehensive geriatric assessment; RI, Rockwood 40-Item Index – frailty; Dindo-Clavien score – postsurgical complications; ECOG Performance Status (ECOG score) – physical performance in oncology; Karnofsky score, physical performance in oncology; ASA, anesthesiologists' physical status; SF-36, 36-item Short Form Survey – quality of life; TUG, Timed up & go.
No missing data.
Parametric t test.